Programmed Cell Death 2-Like (PDCD2L) Peptide
Quick Overview for Programmed Cell Death 2-Like (PDCD2L) Peptide (ABIN8108948)
Target
Source
Application
-
-
Purpose
- PDCD2L Peptide
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-PDCD2L antibody ( ARP50714_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PDCD2L (Programmed Cell Death 2-Like (PDCD2L))
-
Background
-
Background Information: Over expression of PDCD2L attenutates TNF-alpha release in Daudi cells. PDCD2L over-expression restrained proliferation of HEK293T cells. DNA/flow cytometry analysis showed that the over-expression of PDCD2L severely delays cell cycle progression at S phase. These all suggest that PDCD2L might play a role in apoptosis.
Alternative Symbols: MGC13096
-
Molecular Weight
- 39kDa
-
Gene ID
- 84306
-
NCBI Accession
- NP_115722
-
UniProt
- Q9BRP1
Target
-